Historical record - last NADAC effective date: 3/20/2019
Product Information
AMLODIPINE-VALSARTAN 10-160 MG is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.4388 per EA under NDC 43386008203. Its NADAC has been published 204 times since May 13, 2015.
FDA first approved this application on Mar 30, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the amlodipine and valsartan market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
10; 160 mg/1; mg/1
Manufacturer
Lupin Pharmaceuticals Inc.NDC
43386008203
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
3/20/2019
Active Ingredients
AMLODIPINE BESYLATE; VALSARTANApproval Type
Generic (ANDA)
FDA Application
ANDA202829FDA Approved
3/30/2015
TE Code
AB
On Market Since
3/30/2015
Pharmacological Classes
Price Statistics
The NADAC for AMLODIPINE-VALSARTAN 10-160 MG has been published 204 times since May 13, 2015, and over the history we have for it it has declined 91.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4388 per EA |
|---|---|
| All-time high | $4.8784 (May 13, 2015) |
| All-time low | $0.3709 (Nov 21, 2018) |
| Median price | $0.5628 |
| Average price | $0.7733 |
| Largest weekly change | -75.0% (Oct 21, 2015) |
| Weeks tracked | 204 |
| Tracking since | May 13, 2015 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-91.0%
Last surveyed Apr 3, 2019 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 25% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Lupin Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
amlodipine and valsartan market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Angiotensin 2 Receptor Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of AMLODIPINE-VALSARTAN 10-160 MG?
The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-VALSARTAN 10-160 MG, manufactured by Lupin Pharmaceuticals Inc., is $0.4388 per EA (NDC 43386008203), effective Apr 3, 2019.
How has the price of AMLODIPINE-VALSARTAN 10-160 MG changed over time?
Over the history we have for it, the NADAC for AMLODIPINE-VALSARTAN 10-160 MG has declined 91.0%. It has been tracked across 204 weekly CMS publications since May 13, 2015.
What are the highest and lowest recorded NADAC prices for AMLODIPINE-VALSARTAN 10-160 MG?
Since May 13, 2015, the NADAC for AMLODIPINE-VALSARTAN 10-160 MG has ranged from a low of $0.3709 (Nov 21, 2018) to a high of $4.8784 (May 13, 2015), with a median of $0.5628 per EA.
Are there cheaper alternatives to AMLODIPINE-VALSARTAN 10-160 MG?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, AMLODIPINE-VALSARTAN 10-160 MG, is $0.3297 per EA — about 25% below AMLODIPINE-VALSARTAN 10-160 MG.
Who manufactures AMLODIPINE-VALSARTAN 10-160 MG?
AMLODIPINE-VALSARTAN 10-160 MG (NDC 43386008203) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.